Mortality trends due to concomitant cardiovascular disease and cancer in the United States
The Journal of Cardiovascular Aging · 26.05.2026 · 6 (2)
DOI: 10.20517/jca.2025.69 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Cardiovascular Aging, online erschienen am 26.05.2026. Verfasst von Jingfang Cai und 1 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Aim
Cancer and cardiovascular disease (CVD), although often perceived as distinct entities, are complexly interrelated and share numerous common risk factors. Despite increasing attention to deaths from cancer and CVD, studies on mortality trends due to concomitant CVD and cancer remain limited. Therefore, this study sought to assess trends in mortality with both cancer and CVD listed as causes of death in the United States across key demographic and state-level subgroups.
Methods
The data used in this study was obtained from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research dataset and the US Census Bureau. The analysis included deaths occurring from 2000 to 2023 among persons aged 15 years or older with both cancer and CVD listed as causes of death.
Results
From 2000 to 2015, age-adjusted mortality rate due to concomitant cancer and CVD decreased significantly, then declined at a slower and non-significant rate until 2018. After 2018, interestingly, a significant upward trend emerged. This pattern of falling first and then rising was consistent across most demographic subgroups, except for American Indian or Alaska Native and Asian or Pacific Islander population. Notably, the timing of the upward inflection point varied across subgroups, with the youngest individuals (aged 15-44 years) being the first to transition to an upward trend. Geographically, from 2000 to 2015, significant decreases occurred in 41 states (80%). In contrast, from 2015 to 2023, a significant increase was observed in 34 states(66%). Proportion analysis indicates that the observed increase in mortality due to concomitant cancer and CVD represents a true increase in the burden of death due to concomitant cancer and CVD rather than an artifact stemming solely from independent changes in mortality for each individual disease.
Conclusion
These findings underscore the critical need for enhanced intervention strategies targeting mortality risk associated with comorbid due to concomitant cancer and CVD.
Zitieren
APA
Cai, J., & Zhou, B. (2026). Mortality trends due to concomitant cardiovascular disease and cancer in the United States. The Journal of Cardiovascular Aging, 6(2). https://doi.org/10.20517/jca.2025.69
Vancouver
Cai J, Zhou B. Mortality trends due to concomitant cardiovascular disease and cancer in the United States. The Journal of Cardiovascular Aging. 2026;6(2). doi:10.20517/jca.2025.69
BibTeX
@article{Cai2026,
author = {Cai, Jingfang and Zhou, Boda},
title = {Mortality trends due to concomitant cardiovascular disease and cancer in the United States},
journal = {The Journal of Cardiovascular Aging},
year = {2026},
volume = {6},
number = {2},
doi = {10.20517/jca.2025.69}
}
EUVIMED